MedPath

Efficacy and Acceptability of Low-Residue Diet Package (Enimaclin®) as Diet Control Before Colonoscopy

Not Applicable
Completed
Conditions
Dietary Modification
Interventions
Dietary Supplement: Enimaclin®
Other: Self-controlled diet
Drug: 2L PEG-ELS
Drug: low volume 1.5L PEG-ELS
Registration Number
NCT01665157
Lead Sponsor
National Taiwan University Hospital
Brief Summary

The purpose of this study is to evaluate the efficacy and the acceptability of low-residue diet package (Enimaclin®) as diet control before colonoscopy.

Detailed Description

In this study, we investigate a randomized, single-blinded, comparative study to evaluate the efficacy and the acceptability of low-residue diet package (Enimaclin®) as diet control before colonoscopy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
180
Inclusion Criteria
  • Male or female
  • Outpatient or healthy volunteer for health examination, 20~75 years old
  • Eligible for oral bowel preparation
  • BMI (Body Mass Index) ≤ 30
Read More
Exclusion Criteria
  • Patients with severe constipation (as fewer than three stools per week)
  • Patients with bowel obstruction
  • Patients contraindicated with treatment drug
  • Patients who need emergency medication
  • Ineligible for bowel preparation
  • Pregnant or breast-feeding
  • Patients with known allergies to treatment drug or low-residue diet package
  • Patients who are ineligible to enroll
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Self-controlled diet2L PEG-ELSSelf-controlled diet with normal amount of 2L PEG-ELS
Low-residue diet (Enimaclin®) packageEnimaclin®Low-residue diet package with low volume 1.5L PEG-ELS
Low-residue diet (Enimaclin®) packagelow volume 1.5L PEG-ELSLow-residue diet package with low volume 1.5L PEG-ELS
low-residue diet package (Enimaclin®)Enimaclin®Low-residue diet package with normal amount 2L PEG-ELS
low-residue diet package (Enimaclin®)2L PEG-ELSLow-residue diet package with normal amount 2L PEG-ELS
Self-controlled dietSelf-controlled dietSelf-controlled diet with normal amount of 2L PEG-ELS
Primary Outcome Measures
NameTimeMethod
Overall Cleansing Level at Colonoscopy by Ottawa Bowel Preparation Scale1 day

Ottawa preparation scale: Colon is defined into 3 segments: Right(cecum, ascending), mid(transverse, descending), rectosigmoid. Each is scored from 0 to 4, 0 is best and 4 is worst. Fluid quantity of whole is scored as 0, small; 1, moderate; 2 large amount. The scale will be summation of the clearness of 3 segments of colon and overall fluid quantity. It ranged from 0 to 14, 0 is the most clean colon and 14 is the most dirty one. Segment score will be analyzed separately as continuous variable.

Overall Cleansing Level at Colonoscopy by Aronchick Scale1 day

The overall proportion of participants scored as Excellent or Good by Aronchick scale.

Description of Aronchick scale:It categorized colon cleansing into 5 level: Excellent, good, fair, poor, inadequate. It is categorical and cannot be summed. We will present

Total Volume of Purgatives That Ingested1 day

The total volume of PEG-ELS (Liter) that ingested or could be ingested by examinee before colonoscopy

Segmental Cleansing Level at Colonoscopy (Right Segment Preparation Failure)1 day

Segmental score of Ottawa bowel preparation scale was analyzed. The proportion of "right segment" preparation failure, defined as segmental score as "3 poor" or "4 inadequate", was presented.

Secondary Outcome Measures
NameTimeMethod
Willingness to Choose the Same Protocol After Different Low Residual Diet and PEG-ELS Protocol1 day

It represent the proportion of participants who wanted to choose the same protocol as they received in this trial.

Satisfaction of Different Low Residual Diet and Bowel Preparation Protocol1 day

It represented the percentage of participants who is satisfied with the protocol.

Convenience of Different Low Residual Diet and Bowel Preparation Protocol1 day

It represented the percentage of participants who thinks the protocol is easy to use.

Trial Locations

Locations (4)

E-Da Hospital

🇨🇳

Kaohsiung, Taiwan

National Taiwan University Hospital Bei-Hu Branch

🇨🇳

Taipei, Taiwan

Taipei Medical University Hospital

🇨🇳

Taipei, Taiwan

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath